Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study.
Saved in:
| Title: | Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study. |
|---|---|
| Authors: | Harris, John E1 (AUTHOR), Papp, Kim (AUTHOR), Ezzedine, Khaled (AUTHOR), Sebastian, Michael (AUTHOR), Pandya, Amit G (AUTHOR), Seneschal, Julien (AUTHOR), Amster, Mark (AUTHOR), Alam, Maryam Shayesteh (AUTHOR), Forman, Seth B (AUTHOR), Zdybski, Jacek (AUTHOR) |
| Source: | British Journal of Dermatology. Mar2026, Vol. 194 Issue 3, p591-593. 3p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
